Skip to main content
. 2019 Oct 22;9:1116. doi: 10.3389/fonc.2019.01116

Table 3.

Tumor responses.

Responses All patients
(n = 104) [n or %]
BBM
(n = 40) [n or %]
Non-BBM
(n = 64) [n or %]
CR 0 (0.0) 0 0
PR 86 (82.7) 34 (85.0) 52 (81.3)
SD 16 (15.4) 6 (15.0) 10 (15.6)
PD 2 (1.9) 0 2 (3.1)
ORR 82.7%
[95% CI, 75–90%]
85.0%* 81.3%
DCR 98.1%
[95% CI, 95–101%]
100%** 96.9%
*

P = 0.791 vs. Non-BBM.

**

P = 0.522 vs. Non-BBM.

CR, complete response; DCR, disease control rate; ORR, objective response rate; PD, progressive disease; PR, partial response; SD stable disease; BBM, baseline brain-metastases; Non-BMM, without baseline brain-metastases.